Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Brimonidine Tartrate Eye Drops

Approval Number

H20150504

CompanySANDOZ, INC.

Registration Date

April 23, 2020

Previous Approval Numbers

H20150504

Drug Information

Generic Name

酒石酸溴莫尼定滴眼液

Trade Name

沐利汀

Brand Name

沐利汀

Dosage Form

滴眼剂

Strength

5ml:10mg

Drug Type

化学药品

Registration Date

April 23, 2020

Expiry Date

April 22, 2025

Company Information

Applicant Company

Company NameSANDOZ, INC.

Company Address

100 College Rd W, Princeton, NJ 08540 United States of America.

Manufacturing Company

Company NameALCON RESEARCH, LLC

Company Address

6201 South Freeway Fort Worth, Texas 76134

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy